Ledger.Open graph →
SEC Form D · filed October 18, 2022

IMMUNIC, INC

Offering
$60.0M
Sold
$60.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (33)

Andreas Muehler · New York, NYExecDaniel Vitt · New York, NYExec · DirectorBarclay Phillips · New York, NYDirectorGlenn M. Whaley · New York, NYExecHella Kohlhof · New York, NYExecTamar Howson · New York, NYDirectorInderpal M. Singh · New York, NYExecDuane Nash · New York, NYDirectorPatrick Walsh · New York, NYExecPhilippe J. Lavertu · CHICAGO, ILExecCass J. Heckman · CHICAGO, ILExecJames J. Mcmullin · CHICAGO, ILExecJohn J. Twombly · CHICAGO, ILExecRichard T. Brandt, Ii · CHICAGO, ILExec · DirectorOsamu J. Yagi · CHICAGO, ILDirectorTerence R. Grant · CHICAGO, ILExecMala Ramakrishnan · Palo Alto, CADirectorRobert J. Braasch · CHICAGO, ILDirectorVincent Ossipow · New York, NYDirectorMonika M. Tornsen · New York, NYDirectorJorg Neerman · New York, NYDirectorRoy C. Bade · Scottsdale, AZExecJennifer C. Schrader · Scottsdale, AZExec · DirectorJade C. Leung · Scottsdale, AZExecRichard W. Dalton · Eagan, MNExecMark W. Wrightsman · Eagan, MNExecSomsubhra Sikdar · Eagan, MNExecMark Feil · Eagan, MNDirectorJoshua Satin · Los Angeles, CADirectorDamian Langere · Los Angeles, CADirectorVincent Ossipow · New York, NYDirectorMonika M. Tornsen · New York, NYDirectorJorg Neerman · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗